20534206
2010 Jun 7
Small cell lung cancer accounts for about 15% of all cases of lung cancer and is a highly chemo-sensitive disease, but with a high rate of relapse following induction chemotherapy. Small cell lung cancer is often associated with various paraneoplastic syndromes, and we present a case where progression was dominated by a severe endocrine disorder, and present how treatment with the correct chemotherapy improved the patients clinical and biochemical condition.

